Recent WGS News
- GeneDx Announces ultraRapid Whole Genome Sequencing, Delivering Actionable Results in as soon as 48 Hours to Inform Care for Critically Ill NICU and PICU Patients • Business Wire • 02/13/2025 01:30:00 PM
- GeneDx to Participate in 45th Annual TD Cowen Health Care Conference • Business Wire • 02/12/2025 09:05:00 PM
- GeneDx Integrates with Epic, Enabling Broad Adoption of Genome and Exome Sequencing for Health Systems to Inform Patient Diagnosis and Accelerate Treatment • Business Wire • 02/10/2025 01:30:00 PM
- GeneDx to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 18, 2025 • Business Wire • 01/28/2025 09:30:00 PM
- GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 01/17/2025 09:30:00 PM
- GeneDx Announces Preliminary 2024 Financial Results • Business Wire • 01/13/2025 01:30:00 PM
- GeneDx Introduces New Telehealth Pathway to Expand Access to Exome Testing for Parents Seeking Answers • Business Wire • 01/09/2025 01:30:00 PM
- GeneDx Continues its Leadership in Genomics Research, Refining Gene-Disease Relationships and Impacting Results of >22,000 Patients • Business Wire • 01/08/2025 01:30:00 PM
- GeneDx Strengthens Executive Leadership Team with Bryan Dechairo Named Chief Operating Officer • Business Wire • 01/02/2025 09:01:00 PM
- GeneDx to Present at the 43rd Annual J.P. Morgan Healthcare Conference • Business Wire • 12/16/2024 09:05:00 PM
- GeneDx to Expand Access to Exome Testing for Pediatric Epilepsy Patients with New Partners • Business Wire • 12/05/2024 01:30:00 PM
- GeneDx to Participate in Upcoming Investor Conference • Business Wire • 11/22/2024 09:05:00 PM
- GeneDx Fuels Rare Disease Drug Discovery with Launch of GeneDx Discover • Business Wire • 11/19/2024 01:30:00 PM
- GeneDx Announces Heidi Chen as Chief Legal Officer and Corporate Secretary • Business Wire • 11/18/2024 01:30:00 PM
- New GeneDx Study Reveals Racial Disparities in Genetic Diagnosis Due to Systemic Barriers, Not Diagnostic Yields • Business Wire • 11/07/2024 09:35:00 PM
- GeneDx to Highlight Key Research Findings at American Society of Human Genetics (ASHG) Annual Meeting • Business Wire • 11/04/2024 09:35:00 PM
- GeneDx Reports Third Quarter 2024 Financial Results and Business Highlights • Business Wire • 10/29/2024 12:00:00 PM
- Groundbreaking GUARDIAN Study Shows Benefits of Adding Genome Sequencing to Newborn Screening; Augments and Improves Standard Newborn Screening • Business Wire • 10/24/2024 03:10:00 PM
- GeneDx to Showcase Data from Largest Genomic Newborn Screening Cohort of 14,000 Newborns • Business Wire • 10/08/2024 12:30:00 PM
- GeneDx to Report Third Quarter 2024 Financial Results on Tuesday, October 29, 2024 • Business Wire • 10/03/2024 08:05:00 PM
- GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 09/27/2024 08:05:00 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/04/2024 01:35:36 AM
- GeneDx to Participate in Fall Investor Conferences • Business Wire • 08/12/2024 08:05:00 PM
- GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) • Business Wire • 08/09/2024 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/31/2024 08:39:06 PM
COEPTIS Announces the Launch of COEP Venture Group to Invest in AI, RPA, and AI Agent Startups • COEP • Feb 13, 2025 9:10 AM
Unitronix Corp. to Report Over 300% Gains in Cryptocurrency Assets • UTRX • Feb 13, 2025 7:15 AM
Hivello Token ($HVLO) now Live • MATE • Feb 11, 2025 9:27 AM
Animoca Brands leads Hivello funding round ahead of Token Listing • MATEF • Feb 10, 2025 10:20 AM
51 Labs Expands Sports Nutrition Line with Five New Innovative Products, Company in final phase of name and ticker symbol change • CAFI • Feb 10, 2025 9:00 AM
UAV Corp. Expanding in the Global UAV Market, Projected to Exceed $58 Billion by 2027, with Increasing Government and Commercial Sector Adoption • UMAV • Feb 6, 2025 8:30 AM